Article

Testosterone gel now available in metered-dose pump

Unimed Pharmaceuticals said it now offers testosterone gel 1% (AndroGel) in a metered-dose pump.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
Howard Goldman, MD, on his experience with the Glean Urodynamics System
Howard Goldman, MD, on his experience with the Glean Urodynamics System
Remaining Unmet Needs in NMIBC: Closing Thoughts From Expert Panel
Remaining Unmet Needs in NMIBC: Closing Thoughts From Expert Panel
Urology Crossroads: Looking Ahead in the Era of Immunotherapy for NMIBC
Urology Crossroads: Looking Ahead in the Era of Immunotherapy for NMIBC
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Study: Women with SCI are more likely to use indwelling catheters
Discover the Art and Science Behind Nerve Sparing Prostate Surgery
Discover the Art and Science Behind Nerve Sparing Prostate Surgery
Ziho Lee, MD, previews 2025 Northwestern GU robotic reconstruction course
Ziho Lee, MD, previews 2025 Northwestern GU robotic reconstruction course
Christine Ibilibor, MD, highlights study of racial differences in abiraterone use
Christine Ibilibor, MD, highlights study of racial differences in abiraterone use
Vikram Narayran, MD, on tech-driven changes that are enhancing patient care
Vikram Narayran, MD, on tech-driven changes that are enhancing patient care
Justin Dubin, MD, on leveraging digital tools to improve patient buy-in
Justin Dubin, MD, on leveraging digital tools to improve patient buy-in
1 expert is featured in this series.
Approaching Corticosteroid Selection With Abiraterone in Patients With High-Risk Localized or Locally Advanced Prostate Cancer
Related Content
Experts urge FDA to remove black box warning on low-dose vaginal estrogen
July 18th 2025

Experts urge FDA to remove black box warning on low-dose vaginal estrogen

Hannah Clarke
In a panel meeting convened by the FDA, experts urged the agency to revise or remove the outdated boxed warning on hormone therapies for menopause.
Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD
July 15th 2025

Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD

Amy M. Pearlman, MD
Mulhall offers an unfiltered, evidence-based deep dive into testosterone evaluation and treatment nuances.
Urology in focus: Key moments from 2025
July 18th 2025

Urology in focus: Key moments from 2025

Hannah Clarke
Take a look back through some of the top stories from the first half of the year.
Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD
June 30th 2025

Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

Amy M. Pearlman, MD
Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.
FDA, French ANSM greenlight pivotal trial of UroActive smart implant for male SUI
July 17th 2025

FDA, French ANSM greenlight pivotal trial of UroActive smart implant for male SUI

Hannah Clarke Jason M. Broderick
The SOPHIA2 trial will assess the safety and efficacy of the UroActive implant in men with SUI.
FDA grants priority review to NDA for TAR-200 in BCG-unresponsive NMIBC
July 17th 2025

FDA grants priority review to NDA for TAR-200 in BCG-unresponsive NMIBC

Hannah Clarke
The new drug application for TAR-200 is supported by data from cohort 2 of the phase 2b SunRISe-1 trial.
© 2025 MJH Life Sciences

All rights reserved.